Mizuho Securities USA LLC Acquires 187,236 Shares of Colgate-Palmolive (NYSE:CL)

Mizuho Securities USA LLC increased its position in Colgate-Palmolive (NYSE:CL - Free Report) by 296.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 250,499 shares of the company's stock after purchasing an additional 187,236 shares during the quarter. Mizuho Securities USA LLC's holdings in Colgate-Palmolive were worth $26,004,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. E Fund Management Hong Kong Co. Ltd. acquired a new stake in shares of Colgate-Palmolive during the second quarter worth $25,000. Continuum Advisory LLC grew its position in shares of Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company's stock worth $38,000 after buying an additional 125 shares during the period. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at about $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive during the 3rd quarter worth approximately $53,000. Finally, Gradient Investments LLC boosted its stake in Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company's stock worth $65,000 after acquiring an additional 400 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

CL has been the topic of several analyst reports. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a report on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 target price on the stock. UBS Group boosted their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the company a "buy" rating in a research note on Wednesday, September 4th. Morgan Stanley raised their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an "overweight" rating in a research report on Monday, July 29th. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a "buy" rating to a "hold" rating and increased their target price for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. Finally, Stifel Nicolaus downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $105.11.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the company's stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. The trade was a 16.44 % decrease in their position. The disclosure for this sale can be found here. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Stock Performance

Shares of CL stock traded up $2.11 on Friday, reaching $93.56. The stock had a trading volume of 7,328,993 shares, compared to its average volume of 4,387,812. Colgate-Palmolive has a 12 month low of $75.17 and a 12 month high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The firm has a market capitalization of $76.44 billion, a price-to-earnings ratio of 26.81, a P/E/G ratio of 3.25 and a beta of 0.42. The firm's 50-day moving average is $99.31 and its two-hundred day moving average is $98.45.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $0.50 per share. The ex-dividend date was Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. Colgate-Palmolive's dividend payout ratio is currently 57.31%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.